Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.58 |
| ▸ | CES1 | P23141 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28496059 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL2150014 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL5921881 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL2149478 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL5788530 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL2149399 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL3742624 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL7156909 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL5016595 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 | |
| SCHEMBL3829000 | 1.00 | CES2 (0.58) | CES2CES1LMNANAAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3068859-B1 | DISHWASHING COMPOSITION AND USE | WEYLCHEM WIESBADEN GMBH (DE) | 2018-09-12 | — | — | EP | claimed |
| CN-110621675-B | Tricyclic compounds useful for the treatment of proliferative diseases | 阿古诺治疗有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-9340485-B2 | Process for preparing esters from formates and olefinically unsaturated compounds | EVONIK INDUSTRIES AG (DE) | 2016-05-17 | — | — | US | disclosed |
| US-9340485-B2 | Process for preparing esters from formates and olefinically unsaturated compounds | EVONIK INDUSTRIES AG (DE) | 2016-05-17 | — | — | US | disclosed |
| US-20140309435-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | EVONIK INDUSTRIES AG (DE) | 2014-10-16 | — | — | US | disclosed |
| US-20140309435-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | EVONIK INDUSTRIES AG (DE) | 2014-10-16 | — | — | US | disclosed |
| WO-2013092478-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | EVONIK INDUSTRIES AG (DE) | 2013-06-27 | — | — | WO | disclosed |
| CN-1312359-A | Bleaching detergent composition | KAO CORP (JP) | 2001-09-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309435-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | FDPS, ELOVL6, ELOVL3 | CES2 447/4885CES1 236/4885LMNA 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.